These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 17381177)

  • 21. 4D-fingerprints, universal QSAR and QSPR descriptors.
    Senese CL; Duca J; Pan D; Hopfinger AJ; Tseng YJ
    J Chem Inf Comput Sci; 2004; 44(5):1526-39. PubMed ID: 15446810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benchmarking of QSAR models for blood-brain barrier permeation.
    Konovalov DA; Coomans D; Deconinck E; Heyden YV
    J Chem Inf Model; 2007; 47(4):1648-56. PubMed ID: 17602606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robust cross-validation of linear regression QSAR models.
    Konovalov DA; Llewellyn LE; Vander Heyden Y; Coomans D
    J Chem Inf Model; 2008 Oct; 48(10):2081-94. PubMed ID: 18826208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Holographic QSAR of selected esters.
    Chen D; Yin C; Wang X; Wang L
    Chemosphere; 2004 Dec; 57(11):1739-45. PubMed ID: 15519421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total and local (atom and atom type) molecular quadratic indices: significance interpretation, comparison to other molecular descriptors, and QSPR/QSAR applications.
    Ponce YM
    Bioorg Med Chem; 2004 Dec; 12(24):6351-69. PubMed ID: 15556754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ranking of aquatic toxicity of esters modelled by QSAR.
    Papa E; Battaini F; Gramatica P
    Chemosphere; 2005 Feb; 58(5):559-70. PubMed ID: 15620749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atom-based 3D-chiral quadratic indices. Part 2: prediction of the corticosteroid-binding globulinbinding affinity of the 31 benchmark steroids data set.
    Castillo-Garit JA; Marrero-Ponce Y; Torrens F
    Bioorg Med Chem; 2006 Apr; 14(7):2398-408. PubMed ID: 16325409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR analysis of salicylamide isosteres with the use of quantum chemical molecular descriptors.
    Dolezal R; Van Damme S; Bultinck P; Waisser K
    Eur J Med Chem; 2009 Feb; 44(2):869-76. PubMed ID: 18547684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. QSAR of antilipid peroxidative activity of substituted benzodioxoles using chemometric tools.
    Mitra I; Roy K; Saha A
    J Comput Chem; 2009 Dec; 30(16):2712-22. PubMed ID: 19399769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
    Nandi S; Vracko M; Bagchi MC
    Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enantiophore modeling in 3D-QSAR. A data mining application on Whelk-O1 chiral stationary phase.
    Del Rio A; Piras P; Roussel C
    Chirality; 2006 Aug; 18(7):498-508. PubMed ID: 16634132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel TOPP descriptors in 3D-QSAR analysis of apoptosis inducing 4-aryl-4H-chromenes: comparison versus other 2D- and 3D-descriptors.
    Sciabola S; Carosati E; Cucurull-Sanchez L; Baroni M; Mannhold R
    Bioorg Med Chem; 2007 Oct; 15(19):6450-62. PubMed ID: 17658263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR analysis of the toxicity of aromatic compounds to Chlorella vulgaris in a novel short-term assay.
    Netzeva TI; Dearden JC; Edwards R; Worgan AD; Cronin MT
    J Chem Inf Comput Sci; 2004; 44(1):258-65. PubMed ID: 14741035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling robust QSAR. 1. Coding molecules in 3D-QSAR--from a point to surface sectors and molecular volumes.
    Gieleciak R; Magdziarz T; Bak A; Polanski J
    J Chem Inf Model; 2005; 45(5):1447-55. PubMed ID: 16180922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of MOLMAP approach for QSAR modeling of various biological activities using substituent electronic descriptors.
    Hemmateenejad B; Mehdipour AR; Miri R; Shamsipur M
    J Comput Chem; 2009 Oct; 30(13):2001-9. PubMed ID: 19130500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors.
    Larsen SB; Jørgensen FS; Olsen L
    J Chem Inf Model; 2008 Jan; 48(1):233-41. PubMed ID: 18092768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR model for predicting radical scavenging activity of di(hetero)arylamines derivatives of benzo[b]thiophenes.
    Abreu RM; Ferreira IC; Queiroz MJ
    Eur J Med Chem; 2009 May; 44(5):1952-8. PubMed ID: 19118925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D QSAR studies of 1,3,4-benzotriazepine derivatives as CCK2 receptor antagonists.
    Kaur K; Talele TT
    J Mol Graph Model; 2008 Nov; 27(4):409-20. PubMed ID: 18774323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.